RACHEL THOMPSON: Open Payments
NPI 1558457499 · FAIRHOPE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,993 in 163 payments from 16 companies in 2025. Trend: 2023 $2,026 · 2024 $1,931 · 2025 $2,993
Food & beverage: $2,894Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 44 | $802 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 47 | $737 |
| Janssen Biotech, Inc. | 18 | $380 |
| Madrigal Pharmaceuticals | 6 | $255 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $197 |
| Lilly USA, LLC | 6 | $116 |
| Gilead Sciences, Inc. | 6 | $106 |
| Ardelyx, Inc. | 6 | $97 |
| Aimmune Therapeutics, Inc. | 5 | $96 |
| PFIZER INC. | 3 | $58 |
Products named: XIFAXAN, TREMFYA, REZDIFFRA, RINVOQ, LINZESS, SKYRIZI, ENTYVIO, OMVOH.
Industry payments across AL — which companies pay providers there.
